Marker Therapeutics to Present at Three Upcoming September Investor Conferences
HOUSTON, Sept. 7, 2021 /PRNewswire/ -- Marker Therapeutics, Inc. (NASDAQ:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced that the Company will present at three upcoming virtual investor conferences in September.
H.C. Wainwright Annual Global Investment Conference
Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Cantor Fitzgerald Global Healthcare Conference
Live webcasts of the presentations will be accessible from the Investors section of the company's website at markertherapeutics.com and will be available for replay following the event.
About Marker Therapeutics, Inc.
To receive future press releases via email, please visit: https://www.markertherapeutics.com/email-alerts.
View original content to download multimedia:https://www.prnewswire.com/news-releases/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences-301370677.html
SOURCE Marker Therapeutics, Inc.
Company Codes: NASDAQ-NMS:MRKR
© 2021 PR Newswire. All Rights Reserved.